Neutrophil to lymphocyte ratio predicts cardiovascular events in people with type 2 diabetes: post hoc analysis of the SUSTAIN 6 and PIONEER 6 cardiovascular outcomes trials

Subodh Verma; Mansoor Husain; Christian Medom Madsen; Lawrence A Leiter; Anja Birk Kuhlman; Tina Vilsbøll; Søren Rasmussen; Peter Libby

doi:10.1111/dom.15088

Neutrophil to lymphocyte ratio predicts cardiovascular events in people with type 2 diabetes: post hoc analysis of the SUSTAIN 6 and PIONEER 6 cardiovascular outcomes trials

Subodh Verma, Mansoor Husain, Christian Medom Madsen, Lawrence A Leiter, Anja Birk Kuhlman, Tina Vilsbøll, Søren Rasmussen, Peter Libby

Steno Diabetes Center Copenhagen

3 Citationer (Scopus)

Originalsprog	Engelsk
Tidsskrift	Diabetes, Obesity and Metabolism
Vol/bind	25
Udgave nummer	8
Sider (fra-til)	2398-2401
Antal sider	4
ISSN	1462-8902
DOI	https://doi.org/10.1111/dom.15088
Status	Udgivet - aug. 2023

Adgang til dokumentet

10.1111/dom.15088

Andre filer og links

Link to publication in Scopus

Citationsformater

Verma, S., Husain, M., Madsen, C. M., Leiter, L. A., Kuhlman, A. B., Vilsbøll, T., Rasmussen, S., & Libby, P. (2023). Neutrophil to lymphocyte ratio predicts cardiovascular events in people with type 2 diabetes: post hoc analysis of the SUSTAIN 6 and PIONEER 6 cardiovascular outcomes trials. Diabetes, Obesity and Metabolism, 25(8), 2398-2401. https://doi.org/10.1111/dom.15088

Neutrophil to lymphocyte ratio predicts cardiovascular events in people with type 2 diabetes: post hoc analysis of the SUSTAIN 6 and PIONEER 6 cardiovascular outcomes trials. / Verma, Subodh; Husain, Mansoor; Madsen, Christian Medom et al.
I: Diabetes, Obesity and Metabolism, Bind 25, Nr. 8, 08.2023, s. 2398-2401.

Publikation: Bidrag til tidsskrift › Letter › peer review

Verma, S, Husain, M, Madsen, CM, Leiter, LA, Kuhlman, AB, Vilsbøll, T, Rasmussen, S & Libby, P 2023, 'Neutrophil to lymphocyte ratio predicts cardiovascular events in people with type 2 diabetes: post hoc analysis of the SUSTAIN 6 and PIONEER 6 cardiovascular outcomes trials', Diabetes, Obesity and Metabolism, bind 25, nr. 8, s. 2398-2401. https://doi.org/10.1111/dom.15088

@article{1efc1f0c65324c408552d97b74512872,

title = "Neutrophil to lymphocyte ratio predicts cardiovascular events in people with type 2 diabetes: post hoc analysis of the SUSTAIN 6 and PIONEER 6 cardiovascular outcomes trials",

keywords = "Cardiovascular Diseases/epidemiology, Diabetes Mellitus, Type 2/complications, Glucagon-Like Peptide-1 Receptor, Humans, Hypoglycemic Agents, Neutrophils, Risk Factors, cardiovascular disease, type 2 diabetes, GLP-1 analogue, randomized trial, antidiabetic drug",

author = "Subodh Verma and Mansoor Husain and Madsen, {Christian Medom} and Leiter, {Lawrence A} and Kuhlman, {Anja Birk} and Tina Vilsb{\o}ll and S{\o}ren Rasmussen and Peter Libby",

year = "2023",

month = aug,

doi = "10.1111/dom.15088",

language = "English",

volume = "25",

pages = "2398--2401",

journal = "Diabetes, Obesity and Metabolism",

issn = "1462-8902",

publisher = "Wiley-Blackwell Publishing Ltd",

number = "8",

}

TY - JOUR

T1 - Neutrophil to lymphocyte ratio predicts cardiovascular events in people with type 2 diabetes

T2 - post hoc analysis of the SUSTAIN 6 and PIONEER 6 cardiovascular outcomes trials

AU - Verma, Subodh

AU - Husain, Mansoor

AU - Madsen, Christian Medom

AU - Leiter, Lawrence A

AU - Kuhlman, Anja Birk

AU - Vilsbøll, Tina

AU - Rasmussen, Søren

AU - Libby, Peter

PY - 2023/8

Y1 - 2023/8

KW - Cardiovascular Diseases/epidemiology

KW - Diabetes Mellitus, Type 2/complications

KW - Glucagon-Like Peptide-1 Receptor

KW - Humans

KW - Hypoglycemic Agents

KW - Neutrophils

KW - Risk Factors

KW - cardiovascular disease

KW - type 2 diabetes

KW - GLP-1 analogue

KW - randomized trial

KW - antidiabetic drug

UR - http://www.scopus.com/inward/record.url?scp=85158168737&partnerID=8YFLogxK

U2 - 10.1111/dom.15088

DO - 10.1111/dom.15088

M3 - Letter

C2 - 37046366

SN - 1462-8902

VL - 25

SP - 2398

EP - 2401

JO - Diabetes, Obesity and Metabolism

JF - Diabetes, Obesity and Metabolism

IS - 8

ER -